GH Research PLC
GHRS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001855129
No open-market purchases or sales by GH Research PLC insiders were filed in the last 90 days; 63 institutions reported holding it in 13F filings for Q2 2026, worth $1.38B in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in GH Research PLC as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 32
- −1 vs. Q3 2022
- Shares held
- 30.9M
- −696.5K (−2.2%) vs. Q3 2022
- Total value
- $299.5M
- −$67.6M (−18.4%) vs. Q3 2022
- New holders
- 2
- 10 more added
- Sold out
- 3
- 7 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GHRS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 63 | $1.38B |
| Q1 2026 | 54 | $668.5M |
| Q4 2025 | 53 | $591.4M |
| Q3 2025 | 47 | $618.1M |
| Q2 2025 | 38 | $530.9M |
| Q1 2025 | 36 | $470.1M |
| Q4 2024 | 31 | $214.9M |
| Q3 2024 | 28 | $204.2M |
| Q2 2024 | 28 | $354.8M |
| Q1 2024 | 32 | $315.5M |
| Q4 2023 | 35 | $171.7M |
| Q3 2023 | 29 | $291.5M |
| Q2 2023 | 34 | $351.6M |
| Q1 2023 | 29 | $237.2M |
| Q4 2022 | 32 | $299.5M |
| Q3 2022 | 34 | $367.2M |
| Q2 2022 | 35 | $325.0M |
| Q1 2022 | 33 | $587.1M |
| Q4 2021 | 30 | $701.0M |
| Q3 2021 | 30 | $625.2M |
| Q2 2021 | 34 | $593.7M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding GH Research PLC; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Global Retirement Partners, LLC | 220 | $2.14K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 700 | $6.80K | 0.00% | +700 | New |
| Royal Bank of Canada | 1,000 | $10.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 1,177 | $11.0K | 0.00% | −2,206−65.2% | Reduced |
| Bank of America Corp | 2,772 | $26.9K | 0.00% | +2,752+13,760.0% | Added |
| Tortoise Investment Management, LLC | 3,081 | $29.9K | 0.01% | 00.0% | Unchanged |
| BlackRock Inc. | 5,199 | $50.5K | 0.00% | −14,320−73.4% | Reduced |
| State Street Corp | 10,944 | $105.8K | 0.00% | +48+0.4% | Added |
| Exchange Traded Concepts, LLC | 11,510 | $111.3K | 0.00% | +6,435+126.8% | Added |
| Cornerstone Investment Partners, LLC | 14,800 | $143.9K | 0.01% | +14,800 | New |
| PEAK6 Investments LLC | 16,688 | $162.2K | 0.01% | +5,629+50.9% | Added |
| Point72 Asset Management, L.P. | 24,600 | $239.1K | 0.00% | −178,000−87.9% | Reduced |
| AdvisorShares Investments LLC | 29,258 | $282.9K | 0.08% | −798−2.7% | Reduced |
| Barclays PLC | 32,090 | $311.9K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 48,080 | $464.0K | 0.00% | +1,967+4.3% | Added |
| HighVista Strategies LLC | 65,597 | $637.6K | 0.38% | +8,828+15.6% | Added |
| Millennium Management LLC | 69,339 | $671.0K | 0.00% | +59,228+585.8% | Added |
| Mirae Asset Global Investments Co., Ltd. | 105,758 | $1.03M | 0.00% | −20,167−16.0% | Reduced |
| Pura Vida Investments, LLC | 158,327 | $1.54M | 0.26% | 00.0% | Unchanged |
| Acuta Capital Partners, LLC | 243,250 | $2.36M | 1.45% | 00.0% | Unchanged |
| Laurion Capital Management LP | 314,930 | $3.05M | 0.09% | 00.0% | Unchanged |
| Deep Track Capital, LP | 499,400 | $4.85M | 0.21% | 00.0% | Unchanged |
| Morgan Stanley | 524,115 | $5.09M | 0.00% | +34,779+7.1% | Added |
| Cormorant Asset Management, LP | 593,043 | $5.76M | 0.39% | 00.0% | Unchanged |
| Verition Fund Management LLC | 897,860 | $8.68M | 0.17% | +289,736+47.6% | Added |
| Citadel Advisors LLC | 1,281,119 | $12.4M | 0.01% | −6,983−0.5% | Reduced |
| OrbiMed Advisors LLC | 1,622,060 | $15.8M | 0.30% | 00.0% | Unchanged |
| RTW Investments, LP | 2,168,957 | $21.1M | 0.43% | 00.0% | Unchanged |
| VR Adviser, LLC | 3,517,125 | $34.2M | 5.76% | +183,971+5.5% | Added |
| FMR LLC | 4,455,981 | $43.1M | 0.00% | −556,684−11.1% | Reduced |
| Ra Capital Management, L.P. | 4,898,373 | $47.6M | 0.97% | 00.0% | Unchanged |
| BVF Inc | 9,275,158 | $89.7M | 3.79% | 00.0% | Unchanged |
| TimesSquare Capital Management, LLC | 0 | $0 | 0.00% | −463,600−100.0% | Sold out |
| DAFNA Capital Management LLC | 0 | $0 | 0.00% | −52,631−100.0% | Sold out |
| Virtus ETF Advisers LLC | 0 | $0 | 0.00% | −10,026−100.0% | Sold out |
| Jefferies Group LLC | – | – | – | – | Not filed |